Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

M Drolet, É Bénard, MC Boily, H Ali… - The Lancet infectious …, 2015 - thelancet.com
Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

[HTML][HTML] Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from …

M Brisson, É Bénard, M Drolet, JA Bogaards… - The Lancet Public …, 2016 - thelancet.com
Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018

KM Kreisel, IH Spicknall, JW Gargano… - Sexually transmitted …, 2021 - journals.lww.com
Background The most recent estimates of the number of prevalent and incident sexually
transmitted infections (STIs) in the United States were for 2008. We provide updated …

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income …

M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras… - The Lancet, 2020 - thelancet.com
Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …

Human papillomavirus infection and the multistage carcinogenesis of cervical cancer

M Schiffman, N Wentzensen - Cancer epidemiology, biomarkers & …, 2013 - AACR
This short review outlines our understanding of cervical cancer precursors, concentrating on
the central etiologic role of persistent human papillomavirus infection. The stages of cervical …

Estimated prevalence and incidence of disease-associated human papillomavirus types among 15-to 59-year-olds in the United States

RM Lewis, JF Laprise, JW Gargano… - Sexually transmitted …, 2021 - journals.lww.com
Methods Prevalence and incidence were estimated for infections with any HPV (any of 37
types detected using Linear Array) and disease-associated HPV, 2 types that cause …

[HTML][HTML] Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources …

M Drolet, JF Laprise, D Martin, M Jit… - The Lancet Infectious …, 2021 - thelancet.com
Background Introduction of human papillomavirus (HPV) vaccination has been slow in low-
income and middle-income countries (LMICs) because of resource constraints and …

Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States

JF Laprise, HW Chesson, LE Markowitz… - Annals of internal …, 2020 - acpjournals.org
Background: In the United States, the routine age for human papillomavirus (HPV)
vaccination is 11 to 12 years, with catch-up vaccination through age 26 years for women and …

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

L Staadegaard, MM Rönn, N Soni, ME Bellerose… - …, 2022 - thelancet.com
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …

Global elimination of cervical cancer as a public health problem

M Brisson, M Drolet - The Lancet Oncology, 2019 - thelancet.com
Adam Gault/Science Photo Library achieving elimination is possible, and to understand the
potential effects of different screening and human papillomavirus (HPV) vaccination …